Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) / под ред. А.Д.Каприна, В.В.Старин ского, Г.В.Петровой. М., 2018. 250 с. [Malignant neoplasms in Russia in 2017 (morbidity and mortality) / ed. by A.D.Kaprin, V.V.Starinsky, G.V.Petrova. Мoscow, 2018, 250 р. (In Russ.)].

Клинические рекомендации. Рак предстательной железы / Российское общество урологов. Ассоциация онкологов России. Российское общество онкоурологов. Российское общество клинической онкологии [электронный ресурс]. 2018. Режим доступа: http://cr.rosminzdrav.ru/#!/schema/99. (дата обращения 11.05.2019). [Clinical guidelines. Prostate cancer / Russian Society of Urology. Association of Oncologists of Russia Russian Society of Oncourology. Russian Society of Clinical Oncology [electronic resource]. 2018 (In Russ.)].http://cr.rosminzdrav.ru/#!/schema/99

Состояние онкологической помощи населению России в 2018 году / под ред. А.Д.Каприна, В.В.Старинского, Г.В.Петровой. М., 2019. 236 с. [The state of oncological assistance to the population of Russia in 2018 / ed. by A.D.Kaprin, V.V.Starinsky, G.V.Petrova. Мoscow, 2019, 236 р. (In Russ.)].

National Comprehensive Cancer Network. Clinical practice Guidelines in oncology. Prostate cancer [электронный ресурс]. 2019. Режим доступа: www.nccn.org. (дата обращения 11.05.2019).www.nccn.org

D’Amico A.V., Whittington R., Malkowicz S.B. et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era // Cancer. 2002. Vol. 95. Р. 281–286.

Nielsen M.E., Makarov D.V., Humphreys E. et al. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion «nadir +2»? // Urology. 2008. Vol. 72. Р. 1219–1223.

Welz S., Nyazi M., Belka C., Ganswindt U. Surgery vs. radiotherapy in localized prostate cancer. Which is best? // Radiat. Oncol. 2008. Vol. 3. Р. 23. doi: 10.1186/1748–717X-3–23..
DOI: 10.1186/1748–717X-3–23

Dong D.X., Ji Z.G. Current Progress and Controversies in Prostate Cancer Management // Chin. Med. J. (Engl.). 2017. Vol. 130. Р. 2991–2995. doi: 10.4103/0366–6999.220317..
DOI: 10.4103/0366–6999.220317

Chen L., Li Q., Wang Y., Zhang Y., Ma X. Comparison on efficacy of radical prostatectomy versus external beam radiotherapy for the treatment of localized prostate cancer // Oncotarget. 2017. Vol. 45. Р. 79854–79863. doi: 10.18632/oncotarget.20078..
DOI: 10.18632/oncotarget.20078

PI-RADS-2.1 Prostate Imaging and Reporting Data System. Version 2.1 American College of Radiology [электронный ресурс]. 2019. Режим доступа: https://www.acr.org/-/media/ACR/Files/RADS/Pi-RADS/PIRADS-V2-1.pdf?la=en. (дата обращения 11.05.2019).https://www.acr.org/-/media/ACR/Files/RADS/Pi-RADS/PIRADS-V2-1.pdf?la=en

Barentsz J.O., Weinreb J.C., Verma S. et al. Synopsis of the PIRADS v.2 Guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use // Eur. Urol. 2016. Vol. 69. Р. 41–49.

Barrett T., Turkbey B., Choyke P.L. PI-RADS version 2: what you need to know // Clin. Radiol. 2015. Vol. 70. Р. 1165–1176.

Современные стандарты анализа лучевых изображений / под ред. проф. Т.Н.Трофимовой. СПб., 2017. 300 с. [Modern standards for the analysis of radiation images / ed. by prof. T.N.Trofimova. Saint Petersburg, 2017. 300 р. (In Russ.)].

Мищенко А.В., Дубицкий Д.Л. Магнитно-резонансная томография предстательной железы. СПб.: ИПК БИОНТ, 2016. 470 с. [Mishchenko A.V., Dubitsky D.L. Magnetic resonance imaging of the prostate gland. Saint Petersburg: Izdatel’sko-poligraficheskij kompleks BIONT, 2016, 470 р. (In Russ.)].

Gaur S., Turkbey B. Prostate MR Imaging for Posttreatment Evaluation and Recurrence // Radiol. Clin. North. Am. 2017. Vol. 56. Р. 263–275. doi: 10.1016/j.rcl.2017.10.008..
DOI: 10.1016/j.rcl.2017.10.008

Couñago F., Del Cerro E., Díaz-Gavela A.A., Marcos F.J., Recio M., Sanz-Rosa D., Thuissard I., Olaciregui K., Mateo M., Cerezo L. Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy // Springerplus. 2015. Vol. 4. 789 р.

Barchetti F., Panebianco V. Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy // Biomed. Res. Int. 2014. Vol. 2014. Р. 316272.

Cooperberg M.R., Broering J.M., Carroll P.R. Time trends and local variation in primary treatment of localized prostate cancer // J. Clin. Oncol. 2010. Vol. 28. Р. 1117–1123.

Mason M.D., Parulekar W.R., Sydes M.R. et al. Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer // J. Clin. Oncol. 2015. Vol. 33. Р. 2143–2150. doi: 10.1200/JCO.2014.57.7510..
DOI: 10.1200/JCO.2014.57.7510

Michalski J.M., Bae K., Roach M. et al. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 76. Р. 14–22. doi: 10.1016/j.ijrobp.2009.01.062..
DOI: 10.1016/j.ijrobp.2009.01.062

Cookson M.S. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer // J. Urol. 2007. Vol. 177. Р. 540–545.

Akin O., Hricak H. Imaging of prostate cancer // Radiol. Clin. North. Am. 2007. Vol. 45. Р. 207–222.

Roach M., 3rd, Hanks G., Thames H., Schellhammer P., Shipley W.U., Sokol G.H., Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference // Int. J. Radia. Oncol. Biol. Phys. 2006. Vol. 65. Р. 965–974.

Zumsteg Z.S., Spratt D.E., Romesser P.B., Pei X., Zhang Z., PolkinghornW. et al. The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy // European urology. 2015. Vol. 67. Р. 1009–1016. doi: 10.1016/j.eururo.2014.09.028. Epub 2014/10/14..
DOI: 10.1016/j.eururo.2014.09.028. Epub 2014/10/14

Mertan F.V., Greer M.D., Borofsky S. et al. Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer // Top. Magn. Reson. Imaging. 2016. Vol. 25. Р. 139–147. doi: 10.1097/RMR.0000000000000088..
DOI: 10.1097/RMR.0000000000000088

Panje C., Panje T., Putora P.M., et al. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience // Radiat. Oncol. 2015. Vol. 10. Р. 47. doi: 10.1186/s13014-015-0338-3..
DOI: 10.1186/s13014-015-0338-3

Korsholm M.E., Waring L.W., Edmund J.M. A criterion for the reliable use of MRI-only radiotherapy // Radiat. Oncol. 2014. Vol. 9. Р. 16. doi: 10.1186/1748-717X-9-16..
DOI: 10.1186/1748-717X-9-16

Barentsz J.O., Richenberg J., Clements R. et al. ESUR prostate MR guidelines 2012 // Eur. Radiol. 2012. Vol. 22. Р. 746–757.

Pucar D., Hricak H., Shukla-Dave A., Kuroiwa K., Eastham J., Scardino P.T. et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 69. Р. 62–69.

Oppenheimer D.C., Weinberg E.P., Hollenberg G.M., Meyers S.P. Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer // J. Clin. Imaging Sci. 2016. Vol. 6. Р. 18.

Arrayeh E., Westphalen A.C., Kurhanewicz J. et al. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 82. Р. 787–793.

Sala E., Eberhardt S.C., Akin O. et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging // Radiology. 2006. Vol. 238. Р. 176–183.

Ахвердиева Г.И., Санай Э.Б., Панов В.О., Тюрин И.Е., Матвеев В.Б., Шимановский Н.Л. Роль искусственного контрастирования при МРТ-диагностике рака предстательной железы // Медицинская визуализация. 2012. № 1. C. 92–101. [Akhverdiyeva G.I., Sanay E.B., Panov V.O., Tyurin I.E., Matveev V.B., Shimanovsky N.L. The role of artificial contrasting in the MRI diagnosis of prostate cancer. Medical imaging, 2012, No. 1, рр. 92–101 (In Russ.)].

Takayama Y., Kishimoto R., Hanaoka S. et al. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy // J. Magn. Reson. Imaging. 2008. Vol. 27. Р. 1331–1335.

Roy C., Foudi F., Charton J., Jung M., Lang H., Saussine C. et al. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy // AJR Am. J. Roentgenol. 2013. Vol. 200. Р. 361–368.

Akin O., Gultekin D.H., Vargas H.A., Zheng J., Moskowitz C., Pei X. et al. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: Preliminary results // Eur. Radiol. 2011. Vol. 21. Р. 1970–1978.

Kim C.K., Park B.K., Lee H.M. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion- weighted MRI // J. Magn. Reson. Imaging. 2009. Vol. 29. Р. 391–397.

Coakley F.V., Teh H.S., Qayyum A., Swanson M.G., Lu Y., Roach M., 3rd, Pickett B., Shinohara K., Vigneron D.B., Kurhanewicz J. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience // Radiology. 2004. Vol. 233. Р. 441–448.

Pucar D., Shukla-Dave A., Hricak H. et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience // Radiology. 2005. Vol. 236. Р. 545–553.

Westphalen A.C., Coakley F.V., Roach M., McCulloch C.E., Kurhanewicz J. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection // Radiology. 2010. Vol. 256. Р. 485–492.

Ferrer F.A., Miller L.J., Andrawis R.I. et al. Vascular endothelial growth factor expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells // J. Urol. 1997. Vol. 157. Р. 2329–2333.

Terman B.I., Stoletov K.V. VEGF and tumorangiogenesis // The Einstein Quarterly J. Biol. Med. 2001. Vol. 18. Р. 2011.

Adesunloye B.A., Karzai F.H., Danut W.L. Angiogenesis inhibitors in the treatment of prostate cancer // Chem. Immunol. Allergy. 2014. Vol. 99. Р. 197–215.

Zhang K., Waxman D.J. Impact of tumor vascularity of responsiveness to antiangiogenesis in a prostate cancer stem cell-derived tumor model // Mol. Cancer. Ther. 2013. Vol. 12. Р. 787–798.

Low R.N., Fuller D.B., Muradyan N. Dynamic gadolinium-enchanced perfusion MRI of prostate cancer: Assessment of response to hypofractionated robotic stereotactic body radiation therapy // AJR. 2011. Vol. 197. Р. 907–915.

Rouvière O., Valette O., Grivolat S. et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor — correlation with biopsy findings // Urology. 2004. Vol. 63. Р. 922–927.

Haider M.A., Chung P., Sweet J. et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2008. Vol. 70. Р. 425–430.

Donati O.F., Jung S.I., Vargas H.A., Gultekin D.H., Zheng J., Moskowitz C.S. et al. Multiparametric prostate MR imaging with T2- weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: Are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? // Radiology. 2013. Vol. 268. Р. 440–450.

Arumainayagam N., Kumaar S., Ahmed H.U., Moore C.M., Payne H., Freeman A. et al. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy // BJU Int. 2010. Vol. 106. Р. 991–997.

Jalloh M., Leapman M.S., Cowan J.E. et al. Patterns of Local Failure following Radiation Therapy for Prostate Cancer // J. Urol. 2015. Vol. 194. Р. 977–982.